files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
127
Views
2
Downloads

The Possible Link Between Atorvastatin and Cataract inRats: An Experimental Study

Amal Elawady Ebrahim, Mervat Ahmed Aly and Eman Saad Mohamed
Page: 35-40 | Received 21 Sep 2022, Published online: 21 Sep 2022

Full Text Reference XML File PDF File

Abstract

Atorvastatin is a member of drugs known as statins that responsible for lowering lipids to prevent cardiovascular disease. The purpose of this study is to determine potential cataractogenic action of atorvastatin in rats. Almost 75 healthy albino Wistar rats were classified into four groups: Group 1 served as control, Group 2 were animals received hypercholesterolemic diet, Group 3 and 4 that animals received hypercholesterolemic diet with atorvastatin in two doses 1.14 and 11.4 mg/kg/day, respectively. Activity of Na+-K+ ATPase was measured in lens membrane. Soluble lens proteins and Refractive Index (RI) were detected. In addition Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) was done for all the studied groups. A significant decrease (p<0.05) were observed in activity of Na+-K+ ATPase in lens membrane and soluble lens proteins of group 4 that received a high dose of atorvastatin in contrast to all others groups. There were remarkable shifts in molecular weight of all protein fractions detected in pattern of SDS-PAGE come with atorvastatin administrated (Group 4). Also, the same phenomena in appearing no variation in its value of RI to Group 2 or 3 and a significant difference (increase, p<0.05) observed in Group 4. Lens turned out to be reacted to atorvastatin, especially, high doses administrated.


How to cite this article:

Amal Elawady Ebrahim, Mervat Ahmed Aly and Eman Saad Mohamed. The Possible Link Between Atorvastatin and Cataract inRats: An Experimental Study.
DOI: https://doi.org/10.36478/rjmsci.2018.35.40
URL: https://www.makhillpublications.co/view-article/1815-9346/rjmsci.2018.35.40